Jun 10, 2019
Detailed findings from CAROLINA® outcome trial support long-term cardiovascular safety profile of Tradjenta®
Jun 09, 2019
Two RISE Clinical Trials in Youth and Adults with Impaired Glucose Tolerance or Newly Diagnosed Type 2 Diabetes Reveal Surprising Differences in Beta-Cell (b-cell) Function During and After Treatment
Jun 08, 2019
Researchers Find Accelerating Rates of Severe Complications in Young Adults with Youth-Onset Type 2 Diabetes
Jun 04, 2019
U.S. FDA Accepts New Drug Application for Triple Combination Tablet for Adults with Type 2 Diabetes
May 03, 2019
Upsher-Smith Unveils Educational Resources And Support Tools For Migraine Patients
Apr 28, 2019
Victoza® demonstrated superiority in reducing blood sugar vs placebo in children and adolescents with type 2 diabetes
Mar 23, 2019
Oral semaglutide 7 mg and 14 mg doses showed superior reductions in blood sugar and weight compared to sitagliptin at 26 weeks in data presented at ENDO
Nov 19, 2018
Investigation Report on China's Metformin Market (2018-2022)
Oct 30, 2018
U.S. FDA Approves INVOKANA® (canagliflozin) to Reduce the Risk of Heart Attack, Stroke or Cardiovascular Death in Adults with Type 2 Diabetes and Established Cardiovascular Disease
Oct 28, 2018
Diabetes Medication May Protect Against a Common Cause of Blindness
Oct 05, 2018
New Consensus Report From The American Diabetes Association® (ADA) and the European Association for the Study of Diabetes (EASD) Calls for Paradigm Shift to Patient-Centered Care for Type 2 Diabetes
Sep 20, 2018
Bernstein Liebhard LLP Partner Named to Plaintiffs' Executive Committee for Federal Onglyza Heart Failure Lawsuits
Aug 22, 2018
GlucoMe and Merck KGaA, Darmstadt, Germany to Collaborate on Digital Diabetes Management Project in Vietnam
Jun 25, 2018
Metformin Alone or Combined with Insulin Does Not Improve or Preserve Beta-Cell Function in Youth with Impaired Glucose Tolerance or Newly Diagnosed Type 2 Diabetes
Jun 23, 2018
Investigational Doses of Lilly's Once-Weekly Trulicity® (dulaglutide) Show Promise in Delivering Powerful Efficacy in People with Type 2 Diabetes
Apr 13, 2018
Global Dicyandiamide Market Estimated to Reach US$ 535 Mn by 2025; Demand for Anti-diabetic Drugs is Increasing Across the Globe: Transparency Market Research
Feb 26, 2018
New Data Show Lilly's Trulicity® (dulaglutide) in Combination with an SGLT-2 Inhibitor Improves Blood Sugar Control in People with Type 2 Diabetes
Jan 09, 2018
Ozempic® approved in Canada for the treatment of adults with type 2 diabetes
Dec 21, 2017
Federal Judicial Panel to Address Onglyza Lawsuit Consolidation at January 25th Hearing, Bernstein Liebhard LLP Reports
Nov 21, 2017
Health Canada approves Victoza® as the first and only GLP-1 receptor agonist to reduce the risk of cardiovascular death in patients with type 2 diabetes and established cardiovascular disease.